Show walking with you. Com, a specific drug for myelofibrosis such as rukotinib is known. It can be reimbursed through medical insurance, which greatly reduces the economic pressure of patients. Due to the different medical insurance reimbursement policies in different places, patients are also invited to consult the local medical insurance bureau for specific prices and reimbursement ratios. In some areas, the reimbursement rate is 80%, and in some areas it is 70%, so the final price varies greatly.

There is no best treatment for bone marrow fibrosis, and there are not many effective methods. According to the patient's symptoms, measures such as medication, blood transfusion, chemotherapy or surgical resection were taken to control it. Bone marrow fibrosis is a disease caused by the influence of patients' bone marrow hematopoietic function. Most of the disease progresses slowly, and patients may have symptoms such as fatigue, bone and joint pain, hepatosplenomegaly and massive bleeding.